PC3I Program Director @drlolafayanju.bsky.social was recently quoted by Beckers Oncology on how @pennmedicine.bsky.social is utilizing technology such as #telehealth, #artificialintelligence, and data analytics to advance #breastcancer care and care delivery.

Comparing social & behavioral determinants of health (SBDOH) data collection tools in #breastcancer pts showed 1/3 have a social need, underscoring the importance of early SBDOH screening. @ascocancer.bsky.social #ASCOQC25 @drlolafayanju.bsky.social @pennsurgery.bsky.social www.asco.org/abstrac...

PC3I Faculty, Fellows, & staff will present 14 abstracts this weekend at the @ascocancer.bsky.social Quality Care Symposium in Chicago, IL. The work of PC3I researchers aims to reimagine #cancercare delivery for patients, clinicians, & communities. #ASCOQC25 #ASCO pc3i.upenn.edu/news/pc3i-pr...

A project led by PC3I Program Director @drlolafayanju.bsky.social & @upennprc.bsky.social is combining the Best Case/Worst Case framework with the comprehensive geriatric assessment to increase shared decision-making conversations & improve communication & care for older adults with #cancer.

#PC3IatASCO: PC3I's Allie Barz Leahy, Haley Newman, & ‪@kerrycoughlin.bsky.social‬ analyzed pt & caregiver-reported #financialtoxicity (FT) outcomes for #pediatric pts receiving CAR T therapy & found high prevalence of FT at time of infusion. #ASCO25 meetings.asco.org/ab...

Continuing our celebration of National Cancer Research Month #NCRM25: A text-based e-triage screening tool reduced wait times for patients with #cancer by 30 minutes and total care time by 66 minutes per encounter. Led by PC3I Faculty Ronac Mamtani.

Continuing our #NCRM25 celebration: Identifying patient-reported outcome measures for social & behavioral determinants of health (#SBDOH) data collection to improve the equity & efficiency of care for patients with #breastcancer. Led by PC3I Program Director @drlolafayanju.bsky.social

Wrapping up #NCRM25: Implementing a #pediatric-specific tool to collect patient-reported outcomes (#PROs) on subjective symptoms following CAR T Cell therapy to inform an early warning system for #treatmenttoxicity. Led by PC3I Faculty Allison Barz Leahy

PC3I Faculty, Fellows, & staff will present 32 abstracts this weekend at the 2025 @ascocancer.bsky.social Annual Meeting. PC3I's work focuses on delivering patient-centered care, addressing socioeconomic barriers in #oncology, & applying digital interventions to improve patient care. #ASCO25

PC3I Program Director @drlolafayanju.bsky.social recently spoke with Cancer Network about potential initiatives to address racial disparities and other social barriers to receiving guideline-concordant #breastcancer care. #bcsm #Oncsky #cansky

PC3I is seeking change agents in #cancer care and delivery to join us as Faculty and Fellows for FY26! Learn more about the roles here: pc3i.upenn.edu/get-involved... Fill out this form to nominate yourself or someone else by April 18: redcap.med.upenn.edu/surveys/?s=C...

PC3I's Allie Barz Leahy is leading a project to use a pediatric-specific patient-reported outcomes (PROs) tool to collect & characterize symptoms #pediatric patients experience after #CARTcell infusion. Findings will contribute to an early warning system for impending toxicity & relapse. #pedcsm

New research from @erin_bange & @Ron_cology (@penncancer.bsky.social) out in @nejmcatalyst found that implementing a text message-based symptom reporting e-triage reduced time toxicity for patients with cancer @pc3innovation.bsky.social catalyst.nejm.org/doi/full/10....

PC3I is now on BlueSky! The Penn Center for Cancer Care Innovation creates, tests, & scales solutions to improve cancer care delivery, efficiency, & value. Our work spans the entire cancer continuum, from prevention to treatment, survivorship, & end-of-life care. Learn more: pc3i.upenn.edu/our-work/

A study led by @pc3innovation.bsky.social faculty Ronac Mamtani (with PM @kerrycoughlin.bsky.social) showed it’s possible to use digital technology to safely reduce the amount of time some patients with cancer spend receiving care. #innovation #cancercare catalyst.nejm.org/doi/full/10....